COVID – 19 | Vaccination Update – Day 544

ad
Single-shot COVID-19 vaccine protects non-human primates
Single-shot COVID-19 vaccine protects non-human primates

India’s COVID-19 vaccination coverage has crossed 199.25 Crore (1,99,25,57,373today. More than 11 lakh (11,76,456) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10410015
2nd Dose 10076887
Precaution Dose 5949214
FLWs 1st Dose 18426720
2nd Dose 17646793
Precaution Dose 11231058
Age Group 12-14 years 1st Dose 37691311
  2nd Dose 25614995
Age Group 15-18 years 1st Dose 60759889
  2nd Dose 49811935
Age Group 18-44 years 1st Dose 558745459
2nd Dose 505005985
Precaution Dose 4232943
Age Group 45-59 years 1st Dose 203543473
2nd Dose 194354505
Precaution Dose 3149119
Over 60 years 1st Dose 127340553
2nd Dose 121440455
Precaution Dose 27126064
Cumulative 1st dose administered 1016917420
Cumulative 2nd dose administered 923951555
Precaution Dose 51688398
Total 1992557373

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 13th July, 2022 (544th Day)
HCWs 1st Dose 73
2nd Dose 1397
Precaution Dose 21523
FLWs 1st Dose 235
2nd Dose 1925
Precaution Dose 99755
Age Group 12-14 years 1st Dose 57443
  2nd Dose 146891
Age Group 15-18 years 1st Dose 16955
  2nd Dose 65418
Age Group 18-44 years 1st Dose 26825
2nd Dose 205659
Precaution Dose 60400
Age Group 45-59 years 1st Dose 4340
2nd Dose 50940
Precaution Dose 25457
Over 60 years 1st Dose 3781
2nd Dose 33614
Precaution Dose 353825
Cumulative 1st dose administered 109652
Cumulative 2nd dose administered 505844
Precaution Dose 560960
Total 1176456

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply